ITOS
iTeos Therapeutics
ITOS
ITOS
Delisted
ITOS was delisted on the 28th of August, 2025.
71 hedge funds and large institutions have $907M invested in iTeos Therapeutics in 2020 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 24 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
31% more funds holding
Funds holding: 54 → 71 (+17)
5.55% more ownership
Funds ownership: 71.2% → 76.75% (+5.5%)
Holders
71
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$32.1M | |
| 2 | +$13.6M | |
| 3 | +$11.2M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$11.1M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.63M |
Top Sellers
| 1 | -$10M | |
| 2 | -$8.03M | |
| 3 | -$6.76M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$6.17M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.41M |